Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleftherios Michailidis

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 23, 2021
Primary human hepatocyte gene editing: Prometheus' chains are looseningEleftherios Michailidis, Ype P de Jong
Journal of Hepatology|November 7, 2015
Mopping up miRNA: An integrated HBV transcript disrupts liver homeostasis by sequestering miR-122Joseph M Luna, Eleftherios Michailidis, Charles M Rice
Viruses|April 9, 2010
Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse TranscriptaseKamalendra Singh, Bruno Marchand, Karen A Kirby, et al.
Biomolecules|December 24, 2021
RNR-R2 Upregulation by a Short Non-Coding Viral TranscriptKarin Broennimann, Inna Ricardo-Lax, Julia Adler, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2015
Fast hepatitis C virus RNA elimination and NS5A redistribution by NS5A inhibitors studied by a multiplex assay approachDandan Liu, Juan Ji, Tanya P Ndongwe, et al.
Journal of Hepatology|June 1, 2015
Hepatitis B virus induces RNR-R2 expression via DNA damage response activationInna Ricardo-Lax, Vyas Ramanan, Eleftherios Michailidis, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Structural and Mechanistic Basis of F227C-Mediated Hypersusceptibility to Islatravir in HIV-1 Reverse TranscriptaseAlexa A Snyder, Isabella L Kaufman, Jack MacQuillan, et al.
European Journal of Medicinal Chemistry|July 6, 2022
HIV nucleoside reverse transcriptase inhibitorsFranck Amblard, Dharmeshkumar Patel, Eleftherios Michailidis, et al.
Antiviral Research|June 7, 2026
Cell-based platforms for antiviral screening against hepatitis B virus: advantages, limitations, and future perspectivesTaylor M Shue, Allan Henrique Depieri Cataneo, Antonis Athanasiadis, et al.
The International Journal of Biochemistry & Cell Biology|April 26, 2012
Antiviral therapies: focus on hepatitis B reverse transcriptaseEleftherios Michailidis, Karen A Kirby, Atsuko Hachiya, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 23, 2021
Primary human hepatocyte gene editing: Prometheus' chains are looseningEleftherios Michailidis, Ype P de Jong
Journal of Hepatology|November 7, 2015
Mopping up miRNA: An integrated HBV transcript disrupts liver homeostasis by sequestering miR-122Joseph M Luna, Eleftherios Michailidis, Charles M Rice
Viruses|April 9, 2010
Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse TranscriptaseKamalendra Singh, Bruno Marchand, Karen A Kirby, et al.
Biomolecules|December 24, 2021
RNR-R2 Upregulation by a Short Non-Coding Viral TranscriptKarin Broennimann, Inna Ricardo-Lax, Julia Adler, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2015
Fast hepatitis C virus RNA elimination and NS5A redistribution by NS5A inhibitors studied by a multiplex assay approachDandan Liu, Juan Ji, Tanya P Ndongwe, et al.
Journal of Hepatology|June 1, 2015
Hepatitis B virus induces RNR-R2 expression via DNA damage response activationInna Ricardo-Lax, Vyas Ramanan, Eleftherios Michailidis, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Structural and Mechanistic Basis of F227C-Mediated Hypersusceptibility to Islatravir in HIV-1 Reverse TranscriptaseAlexa A Snyder, Isabella L Kaufman, Jack MacQuillan, et al.
European Journal of Medicinal Chemistry|July 6, 2022
HIV nucleoside reverse transcriptase inhibitorsFranck Amblard, Dharmeshkumar Patel, Eleftherios Michailidis, et al.
Antiviral Research|June 7, 2026
Cell-based platforms for antiviral screening against hepatitis B virus: advantages, limitations, and future perspectivesTaylor M Shue, Allan Henrique Depieri Cataneo, Antonis Athanasiadis, et al.
The International Journal of Biochemistry & Cell Biology|April 26, 2012
Antiviral therapies: focus on hepatitis B reverse transcriptaseEleftherios Michailidis, Karen A Kirby, Atsuko Hachiya, et al.
Pageof 8